Chronic Lymphocytic Leukemia Consortium

The Chronic Lymphocytic Leukemia Consortium (CLL Consortium) is a group of researchers and healthcare professionals dedicated to improving the understanding and treatment of chronic lymphocytic leukemia, a type of cancer affecting the blood and bone marrow. By collaborating on studies, sharing data, and developing treatment guidelines, the consortium aims to enhance patient outcomes and advance scientific knowledge about CLL. Their efforts include clinical trials, research initiatives, and education to support both patients and healthcare providers in managing this disease effectively.